A novel blood-based test for early detection of colorectal cancer in average-risk adults met the primary endpoints of sensitivity and specificity in the PREEMPT CRC trial.
A new way of interpreting standard blood tests could help doctors spot cancer warning signs sooner, according to scientists.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback